Anorectal Botulinum Toxin Injection in Functional Constipation – The Jury is Still Out
Topic overview
This commentary examines the efficacy of botulinum toxin injection into the anal sphincter for treating functional constipation in children, questioning whether the reported 79% improvement rate establishes it as a definitive treatment option. The piece critically evaluates long-term outcomes and considers the role of this intervention in pediatric constipation management.
Key takeaways
- Botulinum toxin injection for pediatric functional constipation showed 79% symptom improvement in a 196-patient study.
- Despite promising results, the role of BT as standard treatment for functional constipation remains under debate.
- Long-term efficacy data exists, but clinical consensus on BT use in this population is not yet established.
Keywords
Hashtags
Full article text
Full article text not available for this entry
How to cite: GlobalCastMD. Anorectal Botulinum Toxin Injection in Functional Constipation – The Jury is Still Out. GlobalCastMD Medical Library. 2025-01-06. https://dev.library.globalcastmd.com/article/9606?via_space=staycurrentmd
Comments